BNF:

8.1.5

Status:

Red

Decision Date:

March 2015

Comments

NICE TA 333: for advanced renal cell carcinoma after failure of prior systemic treatment.

Red Drug Classifications

• 1: Requiring specialist assessment to enable patient selection, initiation and ongoing treating
• 2: Requiring long term on-going monitoring of efficacy by a specialist and not suitable for shared care

search again